Literature DB >> 2076909

Legionellosis in heart transplant recipients.

I Horbach1, F J Fehrenbach.   

Abstract

We report on 20 cases of Legionnaires' Disease (LD) in heart transplant recipients during a two-year study. The overall frequency in this setting amounts thus to 17% (20/115). In contrast, the frequency of legionellosis in postoperative cardiac patients without immunosuppression was only 4.7% (4/84). Legionellosis was diagnosed by culture and/or antibody detection in ten (20) as well as by the detection of urinary antigens in all 20 patients. Only nine (20) patients developed pneumonia, whereas five patients presented with nodular infiltrates. The remaining six patients had moderate fever with no signs of lung infection. In contrast to the majority of patients with other underlying diseases, antigen shedding lasted for long periods in most transplant patients. In high risk patients the application of conventional diagnostic methods together with regular urinary antigen testings (i.e. twice a week) may be advantageous for the early diagnosis of Legionella infection.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2076909     DOI: 10.1007/BF01646407

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  8 in total

1.  Rapid detection of Legionella antigen in tissues and body fluids.

Authors:  F J Fehrenbach; I Horbach; B Ruf; D Shurmann; H D Pohle
Journal:  Isr J Med Sci       Date:  1986-10

2.  Measure of immunoglobulin G-, M-, and A-specific titers against Legionella pneumophila and inhibition of titers against nonspecific, gram-negative bacterial antigens in the indirect immunofluorescence test for legionellosis.

Authors:  H W Wilkinson; C E Farshy; B J Fikes; D D Cruce; L P Yealy
Journal:  J Clin Microbiol       Date:  1979-11       Impact factor: 5.948

Review 3.  Symposium on infectious complications of neoplastic disease (Part II). Legionnaires' disease. Aspects of nosocomial infection.

Authors:  R D Meyer
Journal:  Am J Med       Date:  1984-04       Impact factor: 4.965

4.  Onset and duration of urinary antigen excretion in Legionnaires disease.

Authors:  R B Kohler; W C Winn; L J Wheat
Journal:  J Clin Microbiol       Date:  1984-10       Impact factor: 5.948

5.  Infections caused by Legionella micdadei and Legionella pneumophila among renal transplant recipients.

Authors:  J N Dowling; A W Pasculle; F N Frola; M K Zaphyr; R B Yee
Journal:  J Infect Dis       Date:  1984-05       Impact factor: 5.226

6.  Infectious complications in heart transplant recipients receiving cyclosporine and corticosteroids.

Authors:  J M Hofflin; I Potasman; J C Baldwin; P E Oyer; E B Stinson; J S Remington
Journal:  Ann Intern Med       Date:  1987-02       Impact factor: 25.391

7.  Nosocomial Legionnaires' disease. Occurrence in recipients of bone marrow transplants.

Authors:  J W Kugler; J O Armitage; C M Helms; L W Klassen; N E Goeken; G B Ahmann; R D Gingrich; W Johnson; M J Gilchrist
Journal:  Am J Med       Date:  1983-02       Impact factor: 4.965

8.  Simultaneous infections with different serogroups of Legionella pneumophila investigated by routine methods and Fourier transform infrared spectroscopy.

Authors:  I Horbach; D Naumann; F J Fehrenbach
Journal:  J Clin Microbiol       Date:  1988-06       Impact factor: 5.948

  8 in total
  3 in total

Review 1.  Infection in the bone marrow transplant recipient and role of the microbiology laboratory in clinical transplantation.

Authors:  M T LaRocco; S J Burgert
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

2.  Effect of immunosuppressive therapy on the clinical presentation of legionellosis.

Authors:  K Skogberg; P Ruutu; I Koivula; H Jousimies-Somer; V Valtonen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-07       Impact factor: 3.267

3.  Nosocomial legionellosis in three heart-lung transplant patients: case reports and environmental observations.

Authors:  J M Bangsborg; S Uldum; J S Jensen; B G Bruun
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-02       Impact factor: 3.267

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.